Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
0.58
-0.01 (-0.99%)
At close: Jun 02, 2025, 10:25 AM
-0.99% (1D)
| Bid | 0.58 |
| Market Cap | 70.17M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -15.2M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -1.04 |
| Forward PE | 0.62 |
| Analyst | Buy |
| Ask | 0.58 |
| Volume | 168,959 |
| Avg. Volume (20D) | 894,130 |
| Open | 0.59 |
| Previous Close | 0.59 |
| Day's Range | 0.57 - 0.60 |
| 52-Week Range | 0.20 - 0.96 |
| Beta | 2.13 |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+20.24%
Unicycive Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
11 months ago
-26.76%
Unicycive Therapeutics shares are trading lower. The company announced results from the Oxylanthanum Carbonate UNI-OLC-201 pivotal clinical trial.
